Ambey Laboratories SME IPO Details, Financials, Valuation & Peers
Get everything you need to know about the Ambey Laboratories IPO. Explore Ambey Laboratories IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Overview
Ambey Laboratories Limited incorporated on March 20, 1985, is a manufacturer of agrochemical and home hygiene products. Ambey Laboratories specialize in the production of 2,4-D base chemicals, and other agrochemical products, adhering to the highest standards of Environmental, Health, and Safety (EHS). Located in Behror, Rajasthan, spans 5 acres and is equipped with advanced technology including Programmable Logic Controller (PLC) systems and Supervisory Control, ensuring rigorous quality assurance through HPLC, GC, and UV testing at every production stage.
Key Points:
- Product Portfolio:
- Agrochemical Products: Specializes in 2,4-D Acid, 2,4-D Sodium, 2,4-D Amine, 2,4-D Ethyl Ester, Chlorpyriphos, Thiamethoxam, Pretilachlor, Metribuzin, Hexaconazole, and Metalaxyl.
- Home Hygiene Products: Includes black phenyle, white floor cleaner, toilet cleaner, surface floor cleaner, power cleaner, glass cleaner, moth repellent balls, hand wash, bathroom cleaner, and hand sanitizer.
- Manufacturing Capabilities: Equipped with a state-of-the-art facility in Behror, Rajasthan, featuring Programmable Logic Controllers (PLC), Supervisory Control, and advanced Quality Assurance Departments for thorough testing at every production stage.
- Sustainability and Innovation:
- Zero Liquid Discharge (ZLD): The Behror plant operates with zero liquid discharge, ensuring minimal environmental impact.
- Pilot Plans and Downstream Products: Utilizes pilot plans in laboratories to explore downstream products from core intermediaries, meeting and exceeding customer expectations.
- Client Base: Serves large corporations such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Limited.
- Financial Performance: Demonstrates steady revenue growth with a CAGR of 13.24% from FY 2021 to 2023 and maintains strong EBITDA margins.
- Quality Assurance: Ensures high-quality products through rigorous testing methods, including HPLC, GC, and UV analysis.
Objects of the Issue
- To meet out the Working Capital requirements of the Company
- To meet out the General Corporate Purposes
- To meet out the Issue Expenses.
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 04 Jul - 08 Jul 2024 |
| IPO Price Band | ₹ 65 – 68 per share |
| Fresh Issue | 62,58,000 shares ( ₹ 42.55 crore) |
| Offer For Sale | 3,12,000 shares (₹ 2.12 crore) |
| Total IPO Size | Approx ₹ 44.68 crore |
| Face Value | ₹ 10 |
| Listing On | NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 04 Jul 2024 |
| IPO Closing Date | 08 Jul 2024 |
| Basis Of Allotment | 09 Jul 2024 |
| Refunds | 10 Jul 2024 |
| Demat Transfer | 10 Jul 2024 |
| IPO Listing Date | 11 Jul 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Jan 2024 |
|---|---|---|---|---|
| Total Income | 82.42 | 85.11 | 107.43 | 100.44 |
| Total Expenses | 72.01 | 74.26 | 96.41 | 87.64 |
| Net Profit/Loss | 10.34 | 3.57 | 4.57 | 6.03 |
| NPM (*) | 12.65 | 4.23 | 4.36 | 6.01 |
| Total Assets | 44.62 | 55.93 | 57.62 | 86.21 |
| Total Liabilities | 52.48 | 36.86 | 33.98 | 51.90 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Jan 2024 |
|---|---|---|---|---|
| EPS | 21.12 | 7.08 | 2.57 | 3.33 |
| ROE (%) | -80.84 | 63.82 | 21.40 | 20.80 |
| ROCE (%) | 58.51 | 12.53 | 12.75 | 13.14 |
| D/E Ratio | -4.19 | 0.95 | 0.58 | 0.58 |
| Current Ratio | 0.92 | 1.13 | 1.36 | 1.62 |
| EBITDA MARGIN (%) | 12.73 | 12.83 | 10.52 | 12.75 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | Revenue | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|---|
| Ambey Laboratories Limited | 104.82 | 26.46 | 2.57 | 19.33 | 13.32 |
| Atul Ltd | 5,002.00 | 46.90 | 187.05 | 12.03 | 1,555.42 |
| Meghmani Organics Ltd | 2,556.74 | 63.21 | 9.85 | 15.11 | 65.11 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 61.9 |
| Non-Institutional Investor (NII/HNI) | 324.22 |
| Retail Individual Investor (RII) | 195.06 |
| Total | 173.18 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited)
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Company Promoters
- ARCHIT GUPTA
- ARPIT GUPTA
- SARINA GUPTA
- RISHITA GUPTA
Lead Managers
- FAST TRACK FINSEC PRIVATE LIMITED
Company Address
Ambey Laboratories LIMITED
Ground Floor, Property No.555 Tarla Mohalla, Ghitorni , South West Delhi, New Delhi, Delhi, India -110030
Phone: 0124-4000788
Email: cs@ambeylab.com
Website: ambeylab.com
FAQs
- What is the issue size of the Ambey Laboratories SME IPO?The Ambey Laboratories SME IPO has an issue size of Approx ₹ 44.68 crore. This includes a fresh issue of 62,58,000 shares ( ₹ 42.55 crore) and an offer for sale (OFS) of 3,12,000 shares (₹ 2.12 crore).
- What is the price band of the Ambey Laboratories IPO?The price band for the Ambey Laboratories IPO is ₹ 65 – 68 per share.
- What are the bidding dates for the Ambey Laboratories IPO?The Ambey Laboratories IPO will open for bidding on 04 Jul 2024 and close on 08 Jul 2024.
- What is the allotment date for the Ambey Laboratories IPO?The allotment date for the Ambey Laboratories IPO is 09 Jul 2024.
- What is the listing date for the Ambey Laboratories IPO?The listing date for the Ambey Laboratories IPO is 11 Jul 2024.
- What is the Ambey Laboratories IPO grey market premium?The grey market premium (GMP) for the Ambey Laboratories IPO is currently at ₹28, with an expected listing gain of approximately 41.18%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.